Impact of hepatitis B virus infection on the risk of gallbladder polyps: a cohort study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Nam Hee | - |
dc.contributor.author | Kim, Hong Joo | - |
dc.contributor.author | Kang, Ji Hun | - |
dc.date.accessioned | 2023-11-24T03:04:05Z | - |
dc.date.available | 2023-11-24T03:04:05Z | - |
dc.date.created | 2023-11-20 | - |
dc.date.issued | 2023-11 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/192883 | - |
dc.description.abstract | Background/Aims: We aimed to determine whether hepatitis B virus (HBV) or hepatitis C virus (HCV) infection remains an important risk factor for gallbladder polyps (GBPs) in the current context of reduced prevalence of these infections.Methods: The cohort included 392,913 asymptomatic adults who underwent abdominal ultrasonography (US).Results: The prevalence of GBP sized >= 5 mm, >= 10 mm, and overall (< 5, 5-9 and >= 10 mm) was 2.9%, 0.1%, and 12.8%, respectively. The prevalence of hepatitis B surface antigen (HBsAg), hepatitis B core antibody (HBcAb), and hepatitis C antibody (anti-HCV) positivity was 3.2%, 26.7%, and 0.1%, respectively. The GBP risk was significantly increased in HBsAg-positive individuals, with an adjusted odds ratio of 1.66 (95% confidence interval, 1.49-1.85) for GBP >= 5 mm, 2.39 (1.53-3.75) for GBP >= 10 mm, and 1.49 (1.41-1.59) for overall, whereas there was no significant association between anti-HCV positivity and GBP risk. The GBP risk did not increase significantly in individuals who tested negative for HBsAg but positive for HBcAb. Conclusions: The presence of HBsAg may be an independent risk factor for GBP development in the current context of a decreasing prevalence of HBsAg positivity. A more comprehensive evaluation of GBP during abdominal US surveillance of HBsAg-positive individuals may be necessary. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ASSOC INTERNAL MEDICINE | - |
dc.title | Impact of hepatitis B virus infection on the risk of gallbladder polyps: a cohort study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kang, Ji Hun | - |
dc.identifier.doi | 10.3904/kjim.2023.197 | - |
dc.identifier.scopusid | 2-s2.0-85176508939 | - |
dc.identifier.wosid | 001094529100001 | - |
dc.identifier.bibliographicCitation | KOREAN JOURNAL OF INTERNAL MEDICINE, v.38, no.6, pp.844 - 853 | - |
dc.relation.isPartOf | KOREAN JOURNAL OF INTERNAL MEDICINE | - |
dc.citation.title | KOREAN JOURNAL OF INTERNAL MEDICINE | - |
dc.citation.volume | 38 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 844 | - |
dc.citation.endPage | 853 | - |
dc.type.rims | ART | - |
dc.type.docType | Article; Early Access | - |
dc.identifier.kciid | ART003012050 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | METABOLIC SYNDROME | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | LESIONS | - |
dc.subject.keywordPlus | CHINESE | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | ULTRASONOGRAPHY | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordAuthor | Hepatitis B virus | - |
dc.subject.keywordAuthor | Hepatitis C virus | - |
dc.subject.keywordAuthor | Gallbladder neoplasms | - |
dc.identifier.url | https://kjim.org/journal/view.php?doi=10.3904/kjim.2023.197 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.